7,014 Shares in Axon Enterprise, Inc $AXON Purchased by Niles Investment Management LLC

Niles Investment Management LLC bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the fourth quarter, Holdings Channel reports. The fund bought 7,014 shares of the biotechnology company’s stock, valued at approximately $3,983,000. Axon Enterprise accounts for approximately 3.0% of Niles Investment Management LLC’s investment portfolio, making the stock its 11th largest holding.

A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Brighton Jones LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $480,000. NewEdge Advisors LLC increased its stake in shares of Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC increased its stake in shares of Axon Enterprise by 8.4% during the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after purchasing an additional 157 shares in the last quarter. Woodline Partners LP increased its stake in shares of Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after purchasing an additional 2,003 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in shares of Axon Enterprise during the second quarter valued at approximately $284,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 1.0%

Shares of AXON stock opened at $441.73 on Friday. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The firm’s 50 day moving average is $410.34 and its 200 day moving average is $489.19. The stock has a market capitalization of $35.60 billion, a P/E ratio of 177.40, a P/E/G ratio of 8.03 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter last year, the company posted $1.47 earnings per share. The firm’s quarterly revenue was up 33.7% on a year-over-year basis. Research analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 564 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $478.97, for a total value of $270,139.08. Following the sale, the director owned 3,632 shares in the company, valued at approximately $1,739,619.04. This trade represents a 13.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 13,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the transaction, the president owned 169,125 shares in the company, valued at $82,609,106.25. The trade was a 7.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 39,344 shares of company stock valued at $19,267,315 in the last ninety days. Corporate insiders own 4.20% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on AXON. Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. Morgan Stanley set a $600.00 price target on shares of Axon Enterprise in a report on Thursday, May 7th. TD Cowen cut their price target on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. The Goldman Sachs Group set a $535.00 price target on shares of Axon Enterprise in a report on Thursday, May 7th. Finally, Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.